BERNOCCO, Elisa

BERNOCCO, Elisa  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL) 2011 Umberto Vitolo, ; Marco Ladetto, ; Carola Boccomini ; Andrea Evangelista ;Enrica Gamba; Eleonora Russo ; Alessandra Tucci ; Annalisa Chiarenza ; Antonello Pinto ;Amalia De Renzo ;Francesco Zaja; Andrea Gallamini ; Alessia Bari ;Isabel Alvarez ;Elisa Bernocco; Mario Petrini;Guido Parvis ;Benedetta Puccini ; Paolo Corradini ; Tommasina Perrone; Sharon Supekar ; Annalisa Chiappella ; Barbara Botto ; Barbara Mantoan ;Federico De Angelis ;Luca Baldini ;Giuseppe Rossi
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 2011 Barbero D; Drandi D; Lobetti Bodoni C; Bernocco E; Coscia M; Ruggeri M; Boi M; Genuardi E; Monitillo L; Mantoan B; Maffeo C; Barbiero S; Ferrero S; Rossi D; Passera R; Gaidano G; Massaia M; Omedè P; Boccadoro M; Ladetto M
Khorana score and histotype predicts incidence of early venous thromboembolism in Non-Hodgkin lymphomas: A Pooled-Data analysis of 12 clinical trials of fondazione italiana linfomi (FIL) 2017 Santi R.M.; Ceccarelli M.; Bernocco E.; Monagheddu C.; Evangelista A.; Valeri F.; Monaco F.; Vitolo U.; Cortelazzo S.; Cabras M.G.; Spina M.; Baldini L.; Boccomini C.; Chiappella A.; Bari A.; Luminari S.; Visco C.; Calabrese M.; Limberti G.; Levis A.; Contino L.; Ciccone G.; Ladetto M.
PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA 2011 Genuardi, E; Rossi, D; Bernocco, E; Bodoni, Cl; Drandi, D; Coscia, M; Ruggeri, M; Fangazio, M; Ghione, P; Gattei, V; Boccadoro, M; Omede, P; Massaia, M; Gaidano, G; Ladetto, M
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 2017 Ghione, Paola; Genuardi, Elisa; Rossi, Davide; Drandi, Daniela; Mantoan, Barbara; Barbero, Daniela; Bernocco, Elisa; Monitillo, Luigia; Cerri, Michaela; Ruggeri, Marina; Omede, Paola; Deambrogi, Clara; De Paoli, Lorenzo; Passera, Roberto; Coscia, Marta; Cavallo, Federica; Massaia, Massimo; Boccadoro, Mario; Gaidano, Gianluca; Ladetto, Marco; Ferrero, Simone
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom 2011 Elisa Bernocco; Davide Rossi; Elisa Genuardi; Chiara Lobetti-Bodoni; Roberto Passera; Daniela Drandi; Marta Coscia; Marina Ruggeri; Marco Fangazio; Paola Ghione; Daniela Barbero; Barbara Mantoan; Sara Barbiero; Manuela Zanni; Valter Gattei; Luciana Bergui; Paola Omedè; Massimo Massaia; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome 2011 Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 2013 Ferrero S; Monitillo L; Mantoan B; Barbero D; Genuardi E; Barbiero S; Bernocco E; Caracciolo D; Ruella M; Drandi D; Zanni M; Renna F; Lobetti Bodoni C; Gueli A; Passera R; Musto P; Boccadoro M; Tarella C; Ladetto M.
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 2011 Genuardi E; Ruggeri M; Drandi D; Caltagirone S; Mastrocola R; Bernocco E; Lobetti Bodoni C; Boi M; Monitillo L; Mantoan B; Mantella E; Isaia G; Bergui L; Coscia M; Boccadoro M; Massaia M; Omedè P; Ladetto M
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia 2009 D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia 2009 D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 2012 E Genuardi; E Bernocco; D Rossi; C Lobetti-Bodoni; P Ghione; R Bruna; D Drandi; M Coscia; M Ruggeri; M Fangazio; L Monitillo; D Barbero; B Mantoan; S Barbiero; M Zanni; V Gattei; L Bergui; P Omedè; M Massaia; M Boccadoro; G Gaidano; M Ladetto